Company Overview and News

 
Kotak Mahindra Bank Limited - Analysts/Institutional Investor Meet/Con. Call Updates

8h nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
KMBKY KOTAKBANK 500247

 
Kotak Mahindra Bank Limited - Analysts/Institutional Investor Meet/Con. Call Updates

8h nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
KMBKY KOTAKBANK 500247

 
What the 3-way bank merger means for shareholders

12h livemint
The government’s decision to merge three of its banks—Bank of Baroda, Dena Bank and Vijaya Bank—is expected to reduce the capital it needs to pump into these lenders and help clean up their balance sheets. Mint analyses what this means for the banks and their shareholders.
532121 KMBKY KOTAKBANK 500247 DENABANK 532401 VIJAYABANK

1
M-cap of top-10 Sensex falls by Rs 41,660 crore

2018-09-16 thehindubusinessline
RIL’s valuation plunged by Rs 15,180.46 crore to Rs 7,94,074.52 crore, while that of Tata Consultancy Services dipped by Rs 6,278.86 crore to Rs 7,89,949.92 crore.
KMBKY HINDUNILVR TTNQY MRZUY 532500 532540 HDB MARUTI 500180 KOTAKBANK 500696 HDFCBANK TCS 500247 SBAZ

 
Kotak Mahindra Bank Limited - Allotment of ESOP/ESPS

2018-09-12 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
KMBKY KOTAKBANK 500247

 
Kotak Mahindra Bank hits over 4-month low

2018-09-11 thehindubusinessline
Shares of Kotak Mahindra Bank Ltd fell 1.1 per cent to Rs 1,209.85, their lowest since April 30. The stock broke below a support at Rs 1,220.80, the 23.6 per cent Fibonacci retracement level of the uptrend from February 29, 2016 low to July 16, 2018.
KMBKY KOTAKBANK 500247

1
Seven of top 10 firms lose Rs 75,684 cr in m-cap

2018-09-09 thehindubusinessline
Seven of the 10 most valued Indian companies suffered an erosion of Rs 75,684.33 crore from their market valuation last week, with FMCG major HUL taking the steepest hit.
500325 KMBKY RELIANCE HINDUNILVR TTNQY MRZUY 532500 532540 HDB MARUTI 500180 RIGD KOTAKBANK 500696 HDFCBANK TCS 500247 RLNIY SBAZ

 
Kotak Mahindra Bank Limited - Updates

2018-09-07 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
KMBKY KOTAKBANK 500247

4
An evening walk down Dalal Street | Bulls stage a tough fight, helps market cut losses; Nifty ends above 11,450

2018-09-05 moneycontrol
A good recovery in the last hour helped the market close with shallow cuts. The Sensex managed to recover over 250 points from its low point, while the Nifty shed about 70-odd points from its low points. Both indices closed in the red.
SUNILHITEC YESBANK BHRYY KMBKY 532648 YYBKY 532711 534816 KOTAKBANK INFRATEL 500247 500570 TATAMOTORS TTM

 
Kotak Mahindra Bank Limited - Analysts/Institutional Investor Meet/Con. Call Updates

2018-09-05 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
KMBKY KOTAKBANK 500247

 
Check out insider trades for Sept 3; IDFC Bank, LT Finance Tech Mahindra in focus

2018-09-05 moneycontrol
Trident: Trident Group Ltd. (Old Name: Madhuraj Foundation Ltd.) (promoter) bought 15,50,000 shares through market purchase on August 31, 2018
GRUH APARINDS KMBKY RAJTV 532826 GRHFY TCHQY 532755 532259 511288 TECHM 539437 IDFCBANK KOTAKBANK 500247

 
Ebix acquires Miles Software for $19 million

2018-09-05 livemint
Mumbai: Ebix Inc, a US-listed supplier of software and e-commerce services to finance and insurance companies, on Tuesday said that it has acquired Miles Software, an asset and wealth-management services provider, for at least $19 million dollars.
ICICIBANK EBIX KMBKY 532174 IBN KOTAKBANK 500247 SBAZ

4
[email protected]: #39;GDP growth likely to get back to 7.5% ballpark in Q2#39;

2018-09-03 moneycontrol
With India's economy expanding to an over two-year high, clocking 8.2 percent in the April-June quarter, Udayan Mukherjee, Consulting Editor, CNBC-TV18, said that GDP numbers would probably get back to the 7.5 percent going forward. In an interview with Moneycontrol’s Santosh Nair, Mukherjee noted that the fiscal deficit was a problem not only because of crude oil prices, but due to GST collection being continuously under shooting expectations.
BAJAJ-AUTO YESBANK AXB KMBKY INDUSINDBK IBN 532648 YYBKY 532977 TTNQY 532215 AXBKY AXBA ICICIBANK 532540 532187 AXISBANK 532174 KOTAKBANK TCS 500247 500570 TATAMOTORS TTM

Related Articles

RIGL: Rigel Pharmaceuticals Analysis and Research Report

2018-09-18 - Asif

Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...

EKSO: Ekso Bionics Holdings Analysis and Research Report

2018-09-18 - Asif

Overview The company design, develop and sell exoskeleton technology to augment human strength, endurance and mobility. The company's exoskeleton technology serves multiple markets and can be used both by able-bodied users as well as by persons with physical disabilities. Ekso Bionics has sold, rented or leased devices that (a) enable individuals with neurological conditions affecting gait (stroke and spinal cord injury) to rehabilitate and to walk again and (b) allow industrial workers to perform heavy duty work for extended periods. Today, its medical exoskeleton, Ekso GT, is used as a rehabilitation tool to allow physicians and therapists to rehabilitate patients who have suffered a stroke or spinal cord injury. With its unique features designed specifically for hospitals and its proprietary SmartAssist software, Ekso GT allows for the early mobilization of patients, with high step count and high dosage treatments. The intent is to allow the patient’s central nervous syst...

AGRX: Agile Therapeutics Analysis and Research Report

2018-09-18 - Asif

Overview Agile Therapeutics is a forward-thinking women’s healthcare company dedicated to fulfilling the unmet health needs of today’s women. Twirla® and its other current potential product candidates are designed to provide women with contraceptive options that offer greater convenience and facilitate compliance. The company's lead product candidate, Twirla, also known as AG200-15, is a once-weekly prescription contraceptive patch that is at the end of Phase 3 clinical development. Since its inception in 1997, Agile Therapeutics has devoted substantial resources to developing Twirla, building its intellectual property portfolio, business planning, raising capital and providing general and administrative support for these operations. The company incurred research and development expenses of $14.4 million, $20.9 million and $25.6 million during the years ended December 31, 2017, 2016 and 2015, respectively. The company incurred research and development expenses of $2.4 milli...